Related Experiment Video
Updated: Oct 19, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
LncRNA CDKN2B-AS1 contributes to glioma development by regulating the miR-199a-5p/DDR1 axis
Jiachao Lu1, Yuanjun Chen1, Liangbao Wen1
1Department of Neurosurgery, The first affiliated hospital of Guangxi Medical University, Nanning City, Guangxi Zhuang Autonomous Region, P.R. China.
Background:
Although cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) is upregulated in glioma, its function and potential mechanism in glioma remain unclear.
Methods:
CDKN2B-AS1 level in glioma tissues and cell lines LN229, U251, and U87 was measured by qRT-PCR. Loss-of-function assays using short hairpin RNA for CDKN2B-AS1 (sh-CDKN2B-AS1) were performed to evaluate the effect of CDKN2B-AS1 on cell invasion, migration, proliferation, and apoptosis. The relationship among CDKN2B-AS1, miR-199a-5p, and DDR1 was determined by bioinformatics analysis and luciferase reporter assay. Rescue experiments were conducted to explore the function of CDKN2B-AS1 and miR-199a-5p in glioma. An in vivo animal model of lentivirally transduced U87 glioma xenografts in mice was established to confirm the role of CDKN2B-AS1.
Results:
CDKN2B-AS1 is significantly upregulated in glioma tissues and cell lines. CDKN2B-AS1 knockdown significantly inhibits cell proliferation, invasion, and migration, while promoting apoptosis of glioma cell lines U251 and U87. Further, a miR-199a-5p inhibitor attenuates the inhibitory effects of sh-CDKN2B-AS1 on these cell phenotypes. CDKN2B-AS1 positively regulates DDR1 expression by directly sponging miR-199a-5p. Moreover, CDKN2B-AS1 knockdown efficiently inhibits U87 tumor xenograft growth in mice.
Conclusion:
Our study reveals that CDKN2B-AS1 promotes glioma development by regulating the miR-199a-5p/DDR1 axis, suggesting that this lncRNA might be a potential therapeutic target.
Insights
Cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) promotes glioma development by interacting with miR-199a-5p and DDR1. This finding suggests CDKN2B-AS1 as a potential therapeutic target for glioma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioma is a common primary brain tumor with complex molecular underpinnings.
- The role of long non-coding RNAs (lncRNAs) like CDKN2B-AS1 in glioma pathogenesis is increasingly recognized but not fully elucidated.
Purpose of the Study:
- To investigate the functional role of CDKN2B-AS1 in glioma.
- To elucidate the molecular mechanism by which CDKN2B-AS1 influences glioma progression.
- To assess the therapeutic potential of targeting CDKN2B-AS1 in glioma.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure CDKN2B-AS1 expression in glioma tissues and cell lines.
- Loss-of-function studies using short hairpin RNA (sh-CDKN2B-AS1) to assess effects on cell proliferation, invasion, migration, and apoptosis.
- Bioinformatics analysis and luciferase reporter assays to determine interactions between CDKN2B-AS1, miR-199a-5p, and DDR1.
- In vivo xenograft models to validate findings in a living organism.
Main Results:
- CDKN2B-AS1 is significantly upregulated in glioma tissues and cell lines.
- Knockdown of CDKN2B-AS1 inhibits glioma cell proliferation, invasion, and migration, while promoting apoptosis.
- CDKN2B-AS1 positively regulates DDR1 expression by sponging miR-199a-5p, and this axis drives glioma progression.
- CDKN2B-AS1 knockdown suppressed tumor growth in a mouse xenograft model.
Conclusions:
- CDKN2B-AS1 plays a crucial role in promoting glioma development.
- The miR-199a-5p/DDR1 axis is a key mediator of CDKN2B-AS1's oncogenic function in glioma.
- CDKN2B-AS1 represents a promising therapeutic target for glioma treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

